Teva Pharmaceutical Industries Stock News

DUBLIN , Jan. 12, 2022 /PRNewswire/ -- The "Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021" report has been added to ResearchAndMarkets.com''s offering. The Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014- 2021 report provides comprehensive access to available deals and contract documents for over 2,900 clinical stage deals. The report provides a detailed understanding and analysis of how and why companies enter clinical stage partnering deals and provides details of the latest clinical agreements announced in the healthcare sector. Understanding the flexibility of a prospective partner''s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

Teva Pharmaceutical Industries Limited's (TEVA) CEO Kåre Schultz on 40th Annual JPMorgan Healthcare Conference- Conference Call Transcript

Triple-digit returns could be just a click of the buy button away.

A jury in Suffolk County State Supreme Court found Teva Pharmaceutical Industries Ltd (NYSE: TEVA) contributed to New York's opioid epidemic. Next, the court will hold another trial to determine h

Triple-digit returns could be just a click of the buy button away.

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to sha

Shares of Teva Pharmaceutical Industries Ltd. TEVA, -4.57% sank 4.6% in afternoon trading Thursday, reversing an earlier gain of as much as 3.1%, after New York Attorney General Letitia James said a j

CNBC's Courtney Reagan reports on falling Teva Pharmaceutical shares after a jury found the company fueled the opioid epidemic in New York.

Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a setback for a company still facing thousands of other opioid-related lawsuits around the Unite

This mix of growth and value stocks should shine over the long run.

Zacks Industry Outlook Highlights: Dr. Reddy's Laboratories, Teva Pharmaceutical and Amphastar Pharmaceuticals

This mix of growth and value stocks should shine over the long run.

The impact of COVID-19 on the Zacks Medical-Generic Drugs industry remains mixed. The stabilization in price in 2021 and new product launches may provide some respite for RDY, TEVA and AMPH.